244 related articles for article (PubMed ID: 21068204)
41. Role of snus in initiation and cessation of tobacco smoking in Sweden.
Ramström LM; Foulds J
Tob Control; 2006 Jun; 15(3):210-4. PubMed ID: 16728752
[TBL] [Abstract][Full Text] [Related]
42. Urine 4-(methylnitrosamino)-1-(3) pyridyl-1-butanol and cotinine in Alaska native postpartum women and neonates comparing smokers and smokeless tobacco users.
Benowitz NL; Flanagan CA; Thomas TK; Koller KR; Wolfe AW; Renner CC; Hughes C; Decker PA; Hatsukami DK; Murphy NJ; Patten C
Int J Circumpolar Health; 2018 Dec; 77(1):1528125. PubMed ID: 30325719
[TBL] [Abstract][Full Text] [Related]
43. Snus as a smoking cessation aid: a randomized placebo-controlled trial.
Fagerstrom K; Rutqvist LE; Hughes JR
Nicotine Tob Res; 2012 Mar; 14(3):306-12. PubMed ID: 21994343
[TBL] [Abstract][Full Text] [Related]
44. Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users.
Stepanov I; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):885-91. PubMed ID: 15824160
[TBL] [Abstract][Full Text] [Related]
45. Fetal Exposure to Carcinogens With Tobacco Use in Pregnancy: Phase 1 MAW Study Findings.
Flanagan CA; Koller KR; Wolfe AW; Thomas TK; Benowitz NL; Renner CC; Hughes C; Hatsukami DK; Bronars C; Murphy NJ; Day G; Decker PA; Patten CA
Nicotine Tob Res; 2016 Nov; 18(11):2162-2168. PubMed ID: 27190400
[TBL] [Abstract][Full Text] [Related]
46. Chemical characterization of tobacco-free "modern" oral nicotine pouches and their position on the toxicant and risk continuums.
Azzopardi D; Liu C; Murphy J
Drug Chem Toxicol; 2022 Sep; 45(5):2246-2254. PubMed ID: 34034614
[TBL] [Abstract][Full Text] [Related]
47. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.
Benowitz NL; Nardone N; Dains KM; Hall SM; Stewart S; Dempsey D; Jacob P
Addiction; 2015 Oct; 110(10):1667-75. PubMed ID: 26198394
[TBL] [Abstract][Full Text] [Related]
48. Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial.
Joseph AM; Hecht SS; Murphy SE; Lando H; Carmella SG; Gross M; Bliss R; Le CT; Hatsukami DK
Nicotine Tob Res; 2008 Mar; 10(3):471-81. PubMed ID: 18324566
[TBL] [Abstract][Full Text] [Related]
49. The use of snus for quitting smoking compared with medicinal products.
Lund KE; McNeill A; Scheffels J
Nicotine Tob Res; 2010 Aug; 12(8):817-22. PubMed ID: 20622023
[TBL] [Abstract][Full Text] [Related]
50. Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations.
Vardavas CI; Fthenou E; Patelarou E; Bagkeris E; Murphy S; Hecht SS; Connolly GN; Chatzi L; Kogevinas M
Tob Control; 2013 May; 22(3):194-200. PubMed ID: 22253001
[TBL] [Abstract][Full Text] [Related]
51. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
52. Effect of Long-term Nicotine Replacement Therapy vs Standard Smoking Cessation for Smokers With Chronic Lung Disease: A Randomized Clinical Trial.
Ellerbeck EF; Nollen N; Hutcheson TD; Phadnis M; Fitzgerald SA; Vacek J; Sharpe MR; Salzman GA; Richter KP
JAMA Netw Open; 2018 Sep; 1(5):e181843. PubMed ID: 30646142
[TBL] [Abstract][Full Text] [Related]
53. Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers.
Kavvadias D; Scherer G; Cheung F; Errington G; Shepperd J; McEwan M
Biomarkers; 2009 Dec; 14(8):547-53. PubMed ID: 19747086
[TBL] [Abstract][Full Text] [Related]
54. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB
Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757
[TBL] [Abstract][Full Text] [Related]
55. Exposure to a Tobacco-Specific Carcinogen Among Adolescent Smokeless Tobacco Users in Rural California, United States.
Chaffee BW; Jacob P; Couch ET; Benowitz NL
Nicotine Tob Res; 2020 Oct; 22(10):1764-1771. PubMed ID: 31504879
[TBL] [Abstract][Full Text] [Related]
56. Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation.
Zhu AZ; Binnington MJ; Renner CC; Lanier AP; Hatsukami DK; Stepanov I; Watson CH; Sosnoff CS; Benowitz NL; Tyndale RF
Carcinogenesis; 2013 Jan; 34(1):93-101. PubMed ID: 23027621
[TBL] [Abstract][Full Text] [Related]
57. When smokers quit: exposure to nicotine and carcinogens persists from thirdhand smoke pollution.
Matt GE; Quintana PJE; Zakarian JM; Hoh E; Hovell MF; Mahabee-Gittens M; Watanabe K; Datuin K; Vue C; Chatfield DA
Tob Control; 2016 Sep; 26(5):548-556. PubMed ID: 27655249
[TBL] [Abstract][Full Text] [Related]
58. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
Hecht SS; Murphy SE; Carmella SG; Zimmerman CL; Losey L; Kramarczuk I; Roe MR; Puumala SS; Li YS; Le C; Jensen J; Hatsukami DK
J Natl Cancer Inst; 2004 Jan; 96(2):107-15. PubMed ID: 14734700
[TBL] [Abstract][Full Text] [Related]
59. Plasma Cotinine Is Positively Associated with Homocysteine in Smokers but Not in Users of Smokeless Tobacco.
Söderström E; Nilsson TK; Schneede J; Ueland PM; Midttun Ø; Gylling B; Johansson I; Hultdin J
Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769882
[TBL] [Abstract][Full Text] [Related]
60. Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge.
Kotlyar M; Mendoza-Baumgart MI; Li ZZ; Pentel PR; Barnett BC; Feuer RM; Smith EA; Hatsukami DK
Tob Control; 2007 Apr; 16(2):138-42. PubMed ID: 17400953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
